TY  - JOUR

T1  - Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist

JO  - Expert Opinion on Emerging Drugs

PY  - 2020/02/17

AU  - Parker WAE

AU  - Storey RF

ED  - 

DO  - DOI: 10.1080/14728214.2020.1729121

PB  - Taylor & Francis

VL  - 25

IS  - 1

SP  - 1

EP  - 6

Y2  - 2025/11/12

ER  -